Teligent’s president and chief executive officer Jason Grenfell-Gardner says the firm anticipates a pre-approval inspection (PAI) by the US Food and Drug Administration (FDA) at its recently-expanded US manufacturing facility in Buena, New Jersey, in early 2019.
In an investors’ call detailing Teligent’s third-quarter results, Grenfell-Gardner stated that all construction had been completed at the facility and...



